Journalists discuss new Alzheimer’s drug, women’s alcohol consumption, hip-hop and opioids link
Julie Rovner, KHN’s chief correspondent in Washington, discussed the FDA approval of a new drug for Alzheimer’s disease on WAMU’s “1A” on Wednesday.
- Click here for Rovner on WAMU. to listen
KHN correspondent Aneri Pattani discussed the increase in alcohol consumption and abuse by young women in NPR’s “All Things Considered” on Wednesday.
- Click here to hear Pattani on NPR
- Read Pattani’s “Women Now Drink As Much As Men – And Get Sick Earlier”
KHN freelancer Harris Meyer discussed on Tuesday on Newsy and on Wednesday in WCPN’s “The Sound of Ideas” about the approval of a new drug for Alzheimer’s disease by the FDA.
- Click here to see Meyer on Newsy
- Click here to hear Meyer on WCPN
- Read Meyer’s “FDA is considering approval of a lucrative Alzheimer’s drug, but the benefit is dubious”
KHN’s social media manager Chaseedaw Giles discussed Lx’s “First Look” on NBC on Tuesday about opioid use and hip-hop music.
- Click here to watch Giles on NBC Lx
- Read Giles’ “Opioids like ‘slim’ permeate hip-hop culture, but the dangers are downplayed
KHN (Kaiser Health News) is a national newsroom that produces in-depth journalism on health topics. Together with Policy Analysis and Polling, KHN is one of the three major operational programs of the KFF (Kaiser Family Foundation). KFF is a non-profit foundation that provides the country with information on health issues.
USE OUR CONTENT
This story can be republished for free (details).
